Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4C | Q9H3R0 | 10/20 | 0.61 |
| ▸ | KDM5A | P29375 | 8/20 | 0.61 |
| ▸ | KDM5C | P41229 | 1/20 | 0.52 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.52 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.50 |
| ▸ | KDM4A | O75164 | 2/20 | 0.50 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.50 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.44 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.43 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.43 |
| ▸ | PPARG | P37231 | 4/20 | 0.42 |
| ▸ | PPARD | Q03181 | 4/20 | 0.42 |
| ▸ | PPARA | Q07869 | 4/20 | 0.42 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL3412852 | 0.90 | FFAR3 (0.65) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| SCHEMBL718216 | 0.89 | KMT2A (0.56) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| Methane SCHEMBL15776806 | 0.87 | KMT2A (0.54) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| SCHEMBL11239382 | 0.87 | KMT2A (0.54) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| SCHEMBL5525490 | 0.86 | KDM4C (0.70) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| SCHEMBL15745412 | 0.86 | KDM4C (0.62) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| Valeric Acid SCHEMBL3410743 | 0.86 | AKR1B1 (0.58) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| Propionic Acid SCHEMBL3412690 | 0.84 | FFAR3 (0.56) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| Hexanoate SCHEMBL3416214 | 0.84 | AKR1B1 (0.70) | KDM4CKDM5AKDM5CKDM5BPHF8 | |
| SCHEMBL11584728 | 0.84 | KDM4C (0.68) | KDM4CKDM5AKDM5CKDM5BPHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6984754-B1 | Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents | UNIVERSITY OF SASKATCHEWAN TECHNOLOGIES INC. (CA) | 2006-01-10 | — | — | US | claimed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| US-10025011-B2 | Composition, infrared transmission filter and method for manufacturing the same, and infrared sensor | FUJIFILM CORPORATION (JP) | 2018-07-17 | — | — | US | disclosed |
| US-9810821-B2 | Infrared ray cutoff filter | FUJIFILM CORPORATION (JP) | 2017-11-07 | — | — | US | disclosed |
| US-20170237114-A1 | ALL-SOLID-STATE SECONDARY BATTERY, SOLID ELECTROLYTE COMPOSITION AND ELECTRODE SHEET FOR BATTERIES USED IN THE SAME, AND MANUFACTURING METHOD OF ELECTRODE SHEET FOR BATTERIES AND ALL-SOLID-STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2017-08-17 | — | — | US | disclosed |
| US-9632222-B2 | Method for manufacturing a color filter, color filter and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2017-04-25 | — | — | US | disclosed |
| US-9507257-B2 | Method for manufacturing a color filter, color filter and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2016-11-29 | — | — | US | disclosed |
| US-9442373-B2 | Method of producing color filter and solid-state imaging device having colored composition containing color agent | FUJIFILM CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| US-9442374-B2 | Coloring composition, method for manufacturing a color filter using the same, color filter and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2016-09-13 | — | — | US | disclosed |
| US-20160033680-A1 | COMPOSITION FOR FORMING FAR-INFRARED RADIATION SHIELDING LAYER | FUJIFILM CORPORATION (JP) | 2016-02-04 | — | — | US | disclosed |
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-1941861-A1 | WRINKLE-IMPROVING AGENT | Shiseido Company, Limited (JP) | 2008-07-09 | — | — | EP | disclosed |
| EP-1880711-A1 | PARAKERATOSIS INHIBITOR, PORE-SHRINKING AGENT AND EXTERNAL COMPOSITION FOR SKIN | Shiseido Company, Limited (JP) | 2008-01-23 | — | — | EP | disclosed |
| EP-0866705-A4 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO INC (US) | 1999-03-03 | — | — | EP | disclosed |
| EP-0866705-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | Merck & Co., Inc. (US) | 1998-09-30 | — | — | EP | disclosed |
| WO-1997014417-A1 | FIBRINOGEN RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 1997-04-24 | — | — | WO | disclosed |
| EP-0252505-B1 | 1-HYDROXY-3-(N-METHYL-N-PROPYL AMINO)PROPANE-1,1-DIPHOSPHONIC ACID, PROCESS FOR ITS PREPARATION AND MEDICINES CONTAINING THIS COMPOUND | Roche Diagnostics GmbH (DE) | 1992-09-16 | — | — | EP | disclosed |
| US-4942157-A | CALCIUM METABOLISM, BONE DISORDERS | BOEHRINGER MANNHEIM GMBH (DE) | 1990-07-17 | — | — | US | disclosed |
| WO-1988000590-A1 | DIPHOSPHONIUM ACID DERIVATES AND MEDICINES CONTAINING THE SAME | BOEHRINGER MANNHEIM GMBH (DE) | 1988-01-28 | — | — | WO | disclosed |
| EP-0252505-A1 | 1-Hydroxy-3-(N-methyl-N-propyl amino)propane-1,1-diphosphonic acid, process for its preparation and medicines containing this compound | Roche Diagnostics GmbH (DE) | 1988-01-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100035881-A1 | WRINKLE-IMPROVING AGENT | AAAS, GLA, COL14A1 | KDM4C 4349/4885KDM5A 4278/4885KDM5C 4210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.